Literature DB >> 18658026

PI3Kgamma (PI3Kgamma) is essential for efficient induction of CXCR3 on activated T cells.

Joseph Barbi1, Hannah E Cummings, Bao Lu, Steve Oghumu, Thomas Rückle, Christian Rommel, William Lafuse, Caroline C Whitacre, Abhay R Satoskar.   

Abstract

The gamma isoform of PI3Kinase (PI3Kgamma) controls leukocyte chemotaxis by participating in GPCR signaling, and by regulating cellular polarization. Here we show that PI3Kgamma is required for efficient induction of CXC chemokine receptor 3 (CXCR3) on T cells upon activation. T cells from PI3Kgamma(-/-) mice up-regulated CXCR3 less efficiently than wild-type controls both upon activation in vitro as well as during Leishmania mexicana infection. Inhibition of PI3Kinases using wortmannin and LY294002 or blockade of PI3Kgamma activity using a selective inhibitor or PI3Kgamma siRNA suppressed induction of CXCR3 on T cells following activation. Levels of CXCR3 and T-bet mRNA were significantly lower in PI3Kgamma inhibitor-treated T cells, indicating that PI3Kgamma may control CXCR3 expression in part through induction of T-bet. These results reveal a novel role for PI3Kgamma in the induction of CXCR3 on T cells and suggest that PI3Kgamma may regulate leukocyte chemotaxis by controlling the expression of chemokine receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18658026      PMCID: PMC2569163          DOI: 10.1182/blood-2008-02-135715

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

Review 1.  Chemokines and disease.

Authors:  C Gerard; B J Rollins
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

2.  Induction of the chemokine receptor CXCR3 on TCR-stimulated T cells: dependence on the release from persistent TCR-triggering and requirement for IFN-gamma stimulation.

Authors:  Chigusa Nakajima; Takao Mukai; Nobuya Yamaguchi; Yasunari Morimoto; Woong-Ryeon Park; Masayuki Iwasaki; Ping Gao; Shiro Ono; Hiromi Fujiwara; Toshiyuki Hamaoka
Journal:  Eur J Immunol       Date:  2002-06       Impact factor: 5.532

Review 3.  [Chemokines and chemokine receptors in multiple sclerosis].

Authors:  Tatsuro Misu; Kazuo Fujihara; Yasuto Itoyama
Journal:  Nihon Rinsho       Date:  2003-08

4.  CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection.

Authors:  Lucia E Rosas; Joseph Barbi; Bao Lu; Yuko Fujiwara; Craig Gerard; Virginia M Sanders; Abhay R Satoskar
Journal:  Eur J Immunol       Date:  2005-02       Impact factor: 5.532

5.  Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.

Authors:  Montserrat Camps; Thomas Rückle; Hong Ji; Vittoria Ardissone; Felix Rintelen; Jeffrey Shaw; Chiara Ferrandi; Christian Chabert; Corine Gillieron; Bernard Françon; Thierry Martin; Denise Gretener; Dominique Perrin; Didier Leroy; Pierre-Alain Vitte; Emilio Hirsch; Matthias P Wymann; Rocco Cirillo; Matthias K Schwarz; Christian Rommel
Journal:  Nat Med       Date:  2005-08-28       Impact factor: 53.440

6.  SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity.

Authors:  B Cuevas; Y Lu; S Watt; R Kumar; J Zhang; K A Siminovitch; G B Mills
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

7.  TGF-beta1 inhibits T-bet induction by IFN-gamma in murine CD4+ T cells through the protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-1.

Authors:  Il-Kyoo Park; Leonard D Shultz; John J Letterio; James D Gorham
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

8.  Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines.

Authors:  Peter Seiler; Peter Aichele; Silke Bandermann; Anja E Hauser; Bao Lu; Norma P Gerard; Craig Gerard; Stefan Ehlers; Hans J Mollenkopf; Stefan H E Kaufmann
Journal:  Eur J Immunol       Date:  2003-10       Impact factor: 5.532

9.  IFN-gamma-inducible chemokines enhance adaptive immunity and colitis.

Authors:  Udai P Singh; Shailesh Singh; Nuzhat Iqbal; Casey T Weaver; Jerry R McGhee; James W Lillard
Journal:  J Interferon Cytokine Res       Date:  2003-10       Impact factor: 2.607

10.  Requirement of the chemokine receptor CXCR3 for acute allograft rejection.

Authors:  W W Hancock; B Lu; W Gao; V Csizmadia; K Faia; J A King; S T Smiley; M Ling; N P Gerard; C Gerard
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

View more
  13 in total

1.  PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia.

Authors:  Bola S Hanna; Philipp M Roessner; Annika Scheffold; Billy M C Jebaraj; Yasmin Demerdash; Selcen Öztürk; Peter Lichter; Stephan Stilgenbauer; Martina Seiffert
Journal:  Leukemia       Date:  2018-12-20       Impact factor: 11.528

2.  Epigenetic programming of T cells impacts immune reconstitution in hematopoietic stem cell transplant recipients.

Authors:  Kristine Hardy; Corey Smith; Wen Juan Tu; Robert McCuaig; Archana Panikkar; Vijayendra Dasari; Fan Wu; Siok-Keen Tey; Geoffrey R Hill; Rajiv Khanna; Sudha Rao
Journal:  Blood Adv       Date:  2018-03-27

Review 3.  Targeting the PI3K pathway in cancer: are we making headway?

Authors:  Filip Janku; Timothy A Yap; Funda Meric-Bernstam
Journal:  Nat Rev Clin Oncol       Date:  2018-03-06       Impact factor: 66.675

4.  Peripherally circulating CD4⁺ FOXP3⁺ CXCR3⁺ T regulatory cells correlate with renal allograft function.

Authors:  A Hoerning; S Köhler; C Jun; B Tebbe; J Fu; J Menke; B Wilde; S Dolff; T Feldkamp; D M Briscoe; A Kribben; P F Hoyer; O Witzke
Journal:  Scand J Immunol       Date:  2012-09       Impact factor: 3.487

5.  The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL.

Authors:  K Balakrishnan; M Peluso; M Fu; N Y Rosin; J A Burger; W G Wierda; M J Keating; K Faia; S O'Brien; J L Kutok; V Gandhi
Journal:  Leukemia       Date:  2015-04-28       Impact factor: 11.528

6.  Chronic Methadone Use Alters the CD8+ T Cell Phenotype In Vivo and Modulates Its Responsiveness Ex Vivo to Opioid Receptor and TCR Stimuli.

Authors:  Claire Mazahery; Bryan L Benson; Angélica Cruz-Lebrón; Alan D Levine
Journal:  J Immunol       Date:  2020-01-22       Impact factor: 5.422

7.  Discovery of dual inhibitors of the immune cell PI3Ks p110delta and p110gamma: a prototype for new anti-inflammatory drugs.

Authors:  Olusegun Williams; Benjamin T Houseman; Eric J Kunkel; Brian Aizenstein; Randy Hoffman; Zachary A Knight; Kevan M Shokat
Journal:  Chem Biol       Date:  2010-02-26

8.  PI3Kγ drives priming and survival of autoreactive CD4(+) T cells during experimental autoimmune encephalomyelitis.

Authors:  Iain Comerford; Wendel Litchfield; Ervin Kara; Shaun R McColl
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

9.  The novel therapeutic effect of phosphoinositide 3-kinase-γ inhibitor AS605240 in autoimmune diabetes.

Authors:  Jamil Azzi; Robert F Moore; Wassim Elyaman; Marwan Mounayar; Najib El Haddad; Sunmi Yang; Mollie Jurewicz; Ayumi Takakura; Alessandra Petrelli; Paolo Fiorina; Thomas Ruckle; Reza Abdi
Journal:  Diabetes       Date:  2012-03-08       Impact factor: 9.461

Review 10.  The therapeutic implications of immunosuppressive tumor aerobic glycolysis.

Authors:  Bradley I Reinfeld; W Kimryn Rathmell; Tae Kon Kim; Jeffrey C Rathmell
Journal:  Cell Mol Immunol       Date:  2021-07-08       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.